Showing results (71-80 of 84) with videos related to

Sort By:
Pageof 9
Communications Biology|October 2, 2018
Extensive hybridization following a large escape of domesticated Atlantic salmon in the Northwest AtlanticBrendan F Wringe, Nicholas W Jeffery, Ryan R E Stanley, et al.
Evolutionary Applications|June 22, 2018
Genotyping-by-sequencing of genome-wide microsatellite loci reveals fine-scale harvest composition in a coastal Atlantic salmon fisheryIan R Bradbury, Brendan F Wringe, Beth Watson, et al.
JCO Precision Oncology|October 11, 2021
Patients' Expectations of Benefits From Large-Panel Genomic Tumor Testing in Rural Community Oncology PracticesEric C Anderson, John DiPalazzo, Emily Edelman, et al.
Molecular Ecology|January 18, 2025
Population Genomics Reveals Local Adaptation Related to Temperature Variation in Two Stream Frog Species: Implications for Vulnerability to Climate WarmingBrenna R Forester, Amanda S Cicchino, Alisha A Shah, et al.
BMC Cancer|November 26, 2021
Community oncologists' perceptions and utilization of large-panel genomic tumor testingEric C Anderson, Alexandra C Hinton, Christine W Lary, et al.
Frontiers in Oncology|August 9, 2018
nab-Paclitaxel-Based Therapy in Underserved Patient Populations: The ABOUND.70+ Study in Elderly Patients With Advanced NSCLCCorey J Langer, Edward S Kim, Eric C Anderson, et al.
Cancer Medicine|May 3, 2023
Phase 2 study of preoperative chemotherapy with nab-paclitaxel and gemcitabine followed by chemoradiation for borderline resectable or node-positive pancreatic ductal adenocarcinomaEmerson Y Chen, Adel Kardosh, Nima Nabavizadeh, et al.
Molecular Ecology|September 14, 2023
Low-coverage whole genome sequencing for highly accurate population assignment: Mapping migratory connectivity in the American Redstart (Setophaga ruticilla)Matthew G DeSaix, Eric C Anderson, Christen M Bossu, et al.
Eclinicalmedicine|March 27, 2023
Napabucasin plus nab-paclitaxel with gemcitabine versus nab-paclitaxel with gemcitabine in previously untreated metastatic pancreatic adenocarcinoma: an adaptive multicentre, randomised, open-label, phase 3, superiority trialTanios Bekaii-Saab, Takuji Okusaka, David Goldstein, et al.
JCO Precision Oncology|May 10, 2023
The Maine Cancer Genomics Initiative: Implementing a Community Cancer Genomics Program Across an Entire Rural StateJens Rueter, Eric C Anderson, Leah C Graham, et al.
Pageof 9